Dilution of Share Value Through the Exercise of Stock Options
First written in FY2020. 16 of 18 entries say "Materialised", first in FY2021-Q1. Latest entry: FY2026.
Enechange moved to the "Worse" side of this theme in 2021, 1 year after the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
69 other companies' latest entry also says "Materialised".
- FY2026MaterialisedAnnual report
「Increase due to the issuance of new shares upon exercise of stock acquisition rights 277,164 shares」
During the period, 277,164 shares were issued through the exercise of stock acquisition rights, and as of the filing date, the balance of stock acquisition rights for Series 6 through Series 10 totaled ¥45.512 million. - FY2026-H1MaterialisedAnnual report
「10th Series of Stock Acquisition Rights Categories and number of eligible grantees (people) Representative Director of the Company 1 Employees, including executive officers of the Company 5 Company employees 7 Number of stock acquisition rights (units) * 21,300 (Note) 1」
The Company granted 21,300 units of the 10th series of stock acquisition rights, representing 2,130,000 underlying shares, to the Representative Director, employees and company personnel. In addition, 161,112 shares were added through the exercise of stock acquisition rights during the interim period. - FY2025MaterialisedAnnual report
「As of the date of filing this document, the number of potential shares from stock acquisition rights was 5,142,364, equivalent to 10.8% of the total of 42,628,620 issued shares and 5,142,364 potential shares.」
496,236 shares were added through the exercise of stock acquisition rights, and as of the date of filing, potential shares represented 10.8%. The potential for dilution continues to be disclosed, including the remaining 8th and 9th series of stock acquisition rights. - FY2025-H1MaterialisedAnnual report
「1 January 2024–31 March 2024 (Note) 3 70,704 34,790,588 2,942 12,942 2,942 2,942 (Note) 3. The increase resulted from the exercise of stock acquisition rights.」
During the first half of 2024, 125,988 shares were added through the exercise of stock acquisition rights, and dilution events involving an increase in the number of shares continued to occur. - FY2024-Q1MaterialisedAnnual report
「1 January 2024–31 March 2024 (Note) 3 70,704 34,790,588 2,942 12,942 2,942 2,942 (Note) 3. The increase resulted from the exercise of stock acquisition rights.」
During the first quarter of 2024, 70,704 shares were added through the exercise of stock acquisition rights, and dilution events involving an increase in the number of shares continued to occur. - FY2023WorsenedAnnual report
「As of the date of filing this document, the number of potential shares from stock acquisition rights was 4,689,044, equivalent to 11.9% of the total of 34,845,872 issued shares and 4,689,044 potential shares.」
The potential share ratio increased from 7.4% in the previous disclosure to 11.9%. The potential for dilution increased, including the remaining rights under the 8th and 9th series of stock acquisition rights granted in 2024. - FY2023-Q3MaterialisedAnnual report
「As of the date of filing this document, the number of potential shares from stock acquisition rights was 2,457,036, equivalent to 7.4% of the total of 30,900,800 issued shares and 2,457,036 potential shares.」
During the third quarter, 564,480 shares were added through the exercise of stock acquisition rights, and dilution events involving an increase in the number of shares continued. As of the date of filing, potential shares represented 7.4%. - FY2023-Q2MaterialisedAnnual report
「1 April 2023–11 May 2023 147,516 30,289,784 5,604 3,070,100 5,604 3,070,090 12 May 2023–30 June 2023 21,228 30,311,012 1,672 20,107 1,672 3,071,762 (Note) 1. The increase resulted from the exercise of stock acquisition rights.」
During the second quarter, a total of 168,744 shares were added through the exercise of stock acquisition rights, and dilution events involving an increase in the number of shares continued to occur. - FY2023-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
From January to March 2023, 65,628 shares were added through the exercise of stock acquisition rights, and dilution events involving an increase in the number of shares continued to occur. - FY2022MaterialisedAnnual report
「As of the date of filing this document, the number of potential shares from stock acquisition rights was 3,238,692, equivalent to 9.7% of the total of 30,119,144 issued shares and 3,238,692 potential shares.」
During 2022, 610,260 shares were issued through the exercise of stock acquisition rights, and dilution events continued to occur. As of the date of filing, potential shares represented 9.7%. - FY2022-Q3MaterialisedAnnual report
「1 July 2022–30 September 2022 183,456 30,036,848 7,831 3,059,949 7,831 3,059,939 (Note) The increase resulted from the exercise of stock acquisition rights.」
During the third quarter, 183,456 shares were added through the exercise of stock acquisition rights, and dilution events involving an increase in the number of shares continued to occur. - FY2022-Q2MaterialisedAnnual report
「1 April 2022–30 June 2022 115,704 29,853,392 16,062 3,052,118 16,062 3,052,108 (Note) The increase resulted from the exercise of stock acquisition rights.」
During the second quarter, 115,704 shares were added through the exercise of stock acquisition rights, and the increase in shares that could result in dilution continued to occur. - FY2022-Q1MaterialisedAnnual report
「1 January 2022–31 March 2022 (Note) 2 271,308 29,737,688」
During the first quarter, 271,308 shares were added through the exercise of stock acquisition rights, and the increase in shares resulting from the exercise of potential shares continued to occur. - FY2021MaterialisedAnnual report
「As of the date of filing this document, the number of potential shares from stock acquisition rights was 3,733,992, equivalent to 11.2% of the total of 29,677,880 issued shares and 3,733,992 potential shares.」
During the fiscal year, 2,192,256 new shares were issued through the exercise of stock acquisition rights, and dilution events continued to occur. As of the date of filing, potential shares represented 11.2%. - FY2021-Q3MaterialisedAnnual report
「During the cumulative third-quarter consolidated period, capital stock and capital surplus each increased by ¥141.802 million through the exercise of stock acquisition rights.」
The exercise of stock acquisition rights continued during the cumulative third-quarter period, increasing capital stock and capital surplus by ¥141.802 million each. An additional dilution event involving an increase in the number of shares occurred. - FY2021-Q2MaterialisedAnnual report
「During the cumulative second-quarter consolidated period, capital stock and capital surplus each increased by ¥125.803 million through the exercise of stock acquisition rights.」
The exercise of stock acquisition rights continued, with 1,588,068 shares added from April to June 2021. An additional event that could result in dilution of equity value occurred. - FY2021-Q1MaterialisedAnnual report
「1 January 2021–31 March 2021 (Note) 2 113,982 5,952,458 14,528 937,062 14,528 937,052」
During the first quarter, 113,982 shares were issued through the exercise of stock acquisition rights, creating an event that could result in dilution of equity value. - FY2020First statedAnnual report
「As of the date of filing this document, the number of potential shares from stock acquisition rights was 2,031,843, equivalent to 25.4% of the total of 5,952,458 issued shares and 2,031,843 potential shares.」
The Company disclosed that potential shares represented 25.4% of the total of issued shares and other shares.